{"nct_id":"NCT05162066","title":"Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)","status":"TERMINATED","status_verified_date":"2024-04","start_date":"2022-02-18","start_date_type":"ACTUAL","primary_completion_date":"2022-09-23","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BCRX"]}